Dáil Éireann Debate, Tuesday - 26 May 2026
1229. Deputy Ken O'Flynn asked the Minister for Health if the HSE has conducted an international benchmarking on timelines for reimbursement decisions relating to orphan medicines and rare neurological conditions. [39074/26]
Amharc ar fhreagraUnder the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
